# EPIOXA CROSS-LINKING

NDC: 25357-024
Generic name: riboflavin 5-phosphate ophthalmic
Labeler / Manufacturer: Glaukos Corporation
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: KIT
Routes: OPHTHALMIC
Marketing started: 20260116

FDA application: NDA219910

## Active ingredients

—

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"25357-024"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=25357-024
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=13cefc46-337c-41a3-b113-106bfe553bbb